DEF 14A: Scilex Holding Company Sets Date for 2024 Annual Stockholders Meeting

Scilex Holding Company will hold its 2024 Annual Meeting of Stockholders virtually on April 5, 2024, to elect directors and ratify the appointment of Ernst & Young LLP as its independent accounting firm.

Summary

• Scilex Holding Company will conduct its 2024 Annual Meeting of Stockholders virtually on April 5, 2024, at 9:00 a.m. Pacific Time.
• Stockholders of record as of March 6, 2024, are eligible to vote.
• The meeting will address the election of two Class II directors for terms expiring in 2027 and the ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
• The Board of Directors recommends voting for the election of Jay Chun, M.D., Ph.D., and Yue Alexander Wu, Ph.D., as Class II directors and for the ratification of Ernst & Young LLP's appointment.
• The company intends to mail the proxy statement, proxy card, and the Annual Report on Form 10-K for the fiscal year ended December 31, 2023, on or about March 12, 2024.
• As of the record date, there were 166,189,835 shares of Common Stock and 29,057,097 shares of Series A Preferred Stock outstanding.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in tone. The positive sentiment stems from the company's efforts to engage with stockholders and promote sustainability.

Positives

• The virtual-only format of the Annual Meeting lowers costs and aligns with the company's sustainability goals.
• Stockholders have expanded access to the meeting through the live audio webcast.
• The Board of Directors is actively encouraging stockholders to vote and submit questions during the meeting.

Future Outlook

The company aims to ensure stockholders have similar rights and opportunities to participate as they would at an in-person meeting.

Management Comments

• Jaisim Shah, Chief Executive Officer, President and Director: 'We appreciate your continued support of Scilex.'

Industry Context

The move to a virtual-only meeting reflects a broader trend in corporate governance to leverage technology for increased accessibility and cost efficiency.

Comparison to Industry Standards

• Holding virtual-only shareholder meetings is becoming increasingly common, with companies like Sorrento Therapeutics also adopting this approach to reduce costs and improve accessibility.
• The use of Ernst & Young LLP as the independent registered public accounting firm is consistent with industry standards for publicly traded companies, as they are a well-recognized and reputable firm.
• The director compensation structure, including cash retainers and stock options, aligns with typical compensation packages offered by similar-sized companies in the biotech industry.

Stakeholder Impact

• Shareholders are encouraged to participate in the voting process to influence the company's direction.
• The virtual meeting format aims to provide expanded access to all stockholders.
• The election of directors and ratification of the auditor are key decisions that impact the company's governance and financial oversight.

Next Steps

• Stockholders are urged to vote via the Internet or mail as soon as possible.
• Stockholders can attend the Annual Meeting online to vote and submit questions.
• The company will announce preliminary voting results at the Annual Meeting and disclose final results in a Form 8-K filing.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Directors, Ernst & Young, Stockholders, Voting, Scilex Holding Company